Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 14, 2015; 21(26): 8156-8162
Published online Jul 14, 2015. doi: 10.3748/wjg.v21.i26.8156
Published online Jul 14, 2015. doi: 10.3748/wjg.v21.i26.8156
Table 2 Characteristics of pancreatic cancer patients treated with stereotactic body radiotherapy
| Characteristic | n |
| Sex | |
| Male | 18 |
| Female | 7 |
| Age, yr | Median 63 (range: 44-80) |
| Stage1 | |
| T3 | 21 |
| T4 | 4 |
| N0 | 13 |
| N1 | 12 |
| M0 | 9 |
| M1 | 16 |
| Dose (Gy)/No. of fractions | |
| 30-36 Gy/3 | 14 |
| 40-48 Gy/4 | 11 |
| Carbohydrate antigen 19-9 | |
| Positive | 16 |
| Negative | 9 |
| Primary location of tumor | |
| Head of pancreas | 20 |
| Body or tail of pancreas | 5 |
- Citation: Su TS, Liang P, Lu HZ, Liang JN, Liu JM, Zhou Y, Gao YC, Tang MY. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer. World J Gastroenterol 2015; 21(26): 8156-8162
- URL: https://www.wjgnet.com/1007-9327/full/v21/i26/8156.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i26.8156